Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib is effective and safe for treating alopecia areata.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

High kallistatin levels in diabetics worsen wound healing by blocking important cell signals.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.